COVID-19 Updates
-
Xenter, Inc. Continues Rapid Expansion with Appointment of Scott Heuler, SVP of Global Sales and Marketing, and Gary Baldwin as CTO
On the heels of last week’s announcement of the closing of its $12M Series A offering, Xenter, Inc.…
-
Transit Scientific’s XO Score Scoring Sheath Platform Wins Medical Design Award
Transit Scientific”s XO Score Scoring Sheath Platform has been named a winner in the 2021 Medical Design Excellence…
-
Transit Scientific’s Cutting-Edge Scoring Sheath Platform Earns CE Mark Approval
Transit Scientific has announced that its XO Score® Scoring Sheath Platform has received CE Mark clearance in the European…
-
Clene Nanomedicne Receives Healthy Longevity Catalyst Award
Clene Inc. announced on Monday that the company received a Healthy Longevity Catalyst Award from the U.S. National Academy of…
-
ARUP Announces Partnership with TellBio for Use of TellBio’s Novel Circulating Tumor Cells Technology
ARUP Laboratories on May 10 announced it has signed a strategic agreement with Massachusetts-based TellBio Inc. to use…
-
Xenter Closes Series A at $12M; Adds Four Additional Board Members
Xenter has announced the appointment of four additional industry leaders to its Board of Directors and the closing…
-
IDbyDNA Appoints Next-Gen Sequencing Executive Neil Gunn as New CEO
IDbyDNA, the pioneer in precision metagenomics, has appointed Next-Generation Sequencing (NGS) leader Neil Gunn as its new CEO…
-
SINTX Technologies Files Multiple New U.S. and International Patent Applications
This week SINTX Technoloiges announced multiple U.S. and international patent applications for development of new technologies utilizing the…
-
Foldax Named Among Fierce Medtech’s “Fierce 15” Companies of 2020
Foldax was named by Fierce Medtech as one of the 2020 “Fierce 15,” designating it as one of the…
-
Biden Supports IP Waiver for COVID-19 Vaccines
The Biden administration has announced that they will back a waiver of the WTO Trade-Related Aspects of Intellectual…
-
U.S. Study of DiscGenics IDCT Achieves One-Year Follow-Up Milestone
DiscGenics, a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function…
-
Co-Diagnostics, Inc. JV CoSara Diagnostics Recognized for Work Combating COVID-19 Surge in India
Co-Diagnostics’ Indian manufacturing facility, CoSara Diagnostics Pvt. Ltd. (“CoSara,” or the “JV”, a Joint Venture with Synbiotics Ltd)…
-
Canary Speech and Constant Companion Partner to Help Diagnose Behavioral Health Issues
Utah Business Magazine has highlighted a new partnership between Constant Companion and Canary Speech to study how voice technology…
-
UNIVERSITY OF UTAH, ARUP, AND TECHCYTE DEVELOP NANOSPOT.AI, A NEW ULTRA-FAST TEST FOR COVID-19 ANTIBODIES
The University of Utah (the U), ARUP Laboratories, and Techcyte Inc. announced that they have formed a partnership…
-
SDP Oncology Presents New Data from Investigational Pipeline of Novel Cancer Therapeutics at AACR Virtual Annual Meeting I 2021
Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently presented new findings on a range of investigational agents from…
-
PhotoPharmics Innovations Address Global Health Inequalities
PhotoPharmics has announced its intent to leverage its FDA breakthrough device designation, potential streamlined Medicare coverage under CMS’…
-
Innovative Med Tech Startup Xenter Announces Company Launch
Xenter has announced its formal launch in Salt Lake City. Founded in 2020 by seasoned life sciences entrepreneur…
-
Utah’s Recursion Goes Public – Announces Pricing of IPO
Recursion Pharmaceuticals, Inc. today announced the pricing of its initial public offering of its Class A common stock…
-
IONIQ Sciences Announces Dr. Raphael E. Pollock Has Joined Its Medical Advisory Committee
IONIQ Sciences, Inc. recently announced that Raphael E. Pollock, MD, PhD, FACS has joined its Medical Advisory Committee.…
-
FDA Permits Marketing of BioFire COVID-19 Diagnostic Test Using Traditional Premarket Review Process
On March 17, the FDA granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1), a diagnostic test…
-
President Biden Signs $1.9 Trillion COVID-19 Relief Bill
Yesterday, President Biden signed into law the American Rescue Plan (H.R. 1319), a $1.9 trillion COVID-19 relief package…
-
Utah’s Biomerics Announces Expansion of Texas, Costa Rica Operations
Biomerics, headquartered in Salt Lake City, and a leading mid-market medical device contract manufacturer, has announced it is…
-
IONIQ Sciences Finalist in National ‘Buzz of BIO’ Awards
Utah’s own IONIQ Sciences was named a finalist for the prestigious ‘Buzz of BIO 2021’ award in the…
-
Co-Diagnostics, Inc. Partner to Offer At-Home Saliva Collection Kits for CoPrimer™-Based COVID-19 PCR Test Through Walgreens Find Care®
Co-Diagnostics has announced that laboratory partner Clinical Reference Laboratory’s (CRL) FDA-authorized Rapid Response COVID-19 Saliva Test, which uses…
-
The University of Utah and RenalytixAI Partner to Drive Innovation in Kidney Health
Utah’s RenalytixAI and the University of Utah last week announced a partnership to improve kidney health and reduce…
-
2021 BioHive Entrepreneur and Investor Life Sciences Summit BioHive, J.P. Morgan, Pitch Competition, Local, National Investors and More…
ICYMI If you missed the 2021 BioHive Entrepreneur and Investor Life Sciences (E&I) Summit or weren’t able to…
-
American Society of Nephrology and Renalytix Co-Host Virtual Capital Markets Day for Kidney Health
RenalytixAI co-hosted a Capital Markets Day for Kidney Health with the American Society of Nephrology yesterday, Feb. 11.…
-
Attostat is now EVŌQ Nano – Seeks Next Round of Investment Following Antimicrobial Efficacy Studies
Attostat is now EVŌQ Nano! The Utah start-up has a new name, a clean look and a fresh…
-
Novel Embolic Device Used for Arterial and Venous Tumor Treatments
Fluidx Medical Technology has announced successful patient use of the GPX Embolic Device to therapeutically devascularize, or block…
-
MAYOR ERIN MENDENHALL’S SALT LAKE CITY 2021 PLAN INCLUDES BIOHIVE
Last week, Salt Lake City (SLC) Mayor Erin Mendenhall gave her second State of the City address –…
-
Spectrum Solutions Collaborates with UCLA on Saliva-Based Next-Gen Sequencing (NGS) Liquid Biopsy Research for the Early Detection of Lung Cancer
Spectrum Solutions, LLC on January 27 announced it is sponsoring research in collaboration with the UCLA School of…
-
Control Medical Technology Announces New Device Removes Large Blood Clots in 1st Deep Vein Thrombosis (DVT) Patient Use
Control Medical Technology today announced the FDA cleared Control 11F Mechanical Thrombectomy system was used to remove large…
-
SDP Oncology Announces First Patient Dosed in Phase 1/2 Study of TP-0184 for the Treatment of Anemia in Patients with Low or Intermediate Risk Myelodysplastic Syndromes
Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed in…
-
PPP2 Loans Are Now Open
PPP loans have been reopened with an infusion of $284 billion for First Draw and Second Draw loans.…
-
Co-Diagnostics Anticipates Reporting Highest Quarterly Revenue Following Demand for COVID-19 Diagnostic Products
Based on its preliminary internal financial reporting for the fourth quarter 2020, Co-Diagnostics has announced that unaudited quarterly…
-
Clene Nanomedicine Closes Merger with Tottenham Acquisition I Limited; Provides Corporate Update
Clene Nanomedicine, Inc. (Clene) last week announced the closing of a merger with Tottenham Acquisition I Limited (“Tottenham”)…
-
Early Risk Identification at Core of Innovative Kidney Care Partnership Between Renalytix, DaVita
Kidney care innovators Renalytix AI and DaVita are partnering on a new program aimed at slowing disease progression…
-
Early Vaccination Available for Some Life Science Industry Employees
We’ve received more information on channels for vaccine distribution with some positive developments
-
Co-Diagnostics Designs Test to Detect Mutations for New Coronavirus Strain Using CoPrimer™ Platform
Co-Diagnostics has announced that it has completed principal design work for a PCR test that would allow researchers…
-
Vertex Announces FDA Approvals for Expanded Use of Cystic Fibrosis Medicines
Vertex has announced FDA approval of eligibility for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to include people with cystic fibrosis (CF)…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8M Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial…
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
